当前位置:首页 - 行情中心 - 海特生物(300683) - 财务分析

海特生物

(300683)

  

流通市值:27.34亿  总市值:29.36亿
流通股本:1.22亿   总股本:1.31亿

海特生物(300683)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2024年第一季度实现净利润-0.17亿元,每股收益-0.13元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2024年第一季度最新股东权益247809.85万元,未分配利润44053.16万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2024年第一季度最新总资产296533.95万元,负债48724.10万元。

利润表
报告期2024-03-312023-12-312023-09-302023-06-30
营业总收入131,887,548.36602,284,306.91438,429,234.33286,449,829.65
营业总成本185,592,842.22714,276,365.88506,037,628.53329,717,737.62
营业利润-27,890,510.14-143,073,025.29-43,073,876.78-22,784,866.63
利润总额-28,446,014.15-151,986,076.96-49,172,883.98-24,718,209.26
净利润-17,491,671.96-128,243,404.17-29,616,167.81-12,817,118.68
其他综合收益----
综合收益总额-17,491,671.96-128,243,404.17-29,616,167.81-12,817,118.68
资产负债表
报告期2024-03-312023-12-312023-09-302023-06-30
流动资产合计1,470,633,737.371,488,199,258.131,588,041,406.571,632,453,652.32
非流动资产合计1,494,705,775.141,483,051,898.491,338,832,453.121,307,432,384.05
资产总计2,965,339,512.512,971,251,156.622,926,873,859.692,939,886,036.37
流动负债合计311,033,839.45346,146,004.93254,958,833.99247,188,416.91
非流动负债合计176,207,172.6129,584,316.8777,766,954.5281,750,499.15
负债合计487,241,012.05475,730,321.8332,725,788.51328,938,916.06
归属于母公司股东权益合计2,461,679,083.062,478,155,270.842,572,538,619.152,587,850,358.31
股东权益合计2,478,098,500.462,495,520,834.822,594,148,071.182,610,947,120.31
负债和股东权益合计2,965,339,512.512,971,251,156.622,926,873,859.692,939,886,036.37
现金流量表
报告期2024-03-312023-12-312023-09-302023-06-30
经营活动现金流入小计189,814,464.7681,933,291.07488,848,937.13341,940,741.45
经营活动现金流出小计180,670,148.35676,619,034532,628,822.29373,096,837.67
经营活动产生的现金流量净额9,144,316.355,314,257.07-43,779,885.16-31,156,096.22
投资活动现金流入小计173,415,004.751,484,802,513.911,094,330,476.44915,225,670.15
投资活动现金流出小计224,684,303.111,976,732,188.711,579,215,704.551,493,382,457.71
投资活动产生的现金流量净额-51,269,298.36-491,929,674.8-484,885,228.11-578,156,787.56
筹资活动现金流入小计-299,999,984.56299,999,984.56289,999,984.56
筹资活动现金流出小计4,798,128.5251,709,342.5237,062,068.3935,862,068.39
筹资活动产生的现金流量净额-4,798,128.52248,290,642.04262,937,916.17254,137,916.17
汇率变动对现金及现金等价物的影响53.2912,957.7639,912.5439,912.61
现金及现金等价物净增加额-46,923,057.24-238,311,817.93-265,687,284.56-355,135,055
期末现金及现金等价物余额463,241,985.11510,165,042.35482,790,575.72393,341,805.28
TOP↑